Author:
Yu Fei,Wang Yue,Yu Caiyuan,Zhang Wei,Bai Xuefeng
Abstract
AbstractmiR-18a has been identified as a significantly expressed microRNA (miRNA) in non-small cell lung cancer (NSCLC) and plays a vital role in cancer cell transformation, metastasis, and carcinogenesis. Herein, a pair of binary probes from numerous probe pairs based on single nucleotide polymorphism analyses of miR-18a and miR-18b was first designed and screened to develop a Y-shaped ratio biosensor for accurate detection of serum miR-18a in NSCLC. The special structure of the binary probes combined with the hairpin showed strong specificity for miR-18a, which was confirmed by polyacrylamide gel electrophoresis assay and square wave voltammetry assay. Furthermore, it is beneficial to immobilize single-stranded DNA (ssDNA) probes due to the large specific surface area of nanoporous gold, thereby improving the sensitivity of the biosensor. The Y-shaped ratio biosensor exhibited a wide detection range and can quantify the concentration of miR-18a in the range of 10 fmol/L–100 pmol/L, with a limit of detection of 0.211 fmol/L (S/N = 3). Moreover, it exhibits excellent detection capabilities in serum samples since the biosensor showed a high selectivity toward the coexistence of miR-18a and miR-18b. Therefore, the prepared Y-shaped ratio biosensor is a highly sensitive and specific miR-18a detection tool, capable of identifying microscopic amounts of miR-18a in serum samples, providing great potential for early screening of NSCLC.
Funder
Department of Science and Technology of Guangdong Province
Science and Technology Development Fund, Macau SAR
Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Li W, Liu J-B, Hou L-K, Yu F, Zhang J, Wu W, Tang X-M, Sun F, Lu H-M, Deng J, et al. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring. Mol Cancer. 2022;21(1):1–15.
2. Komatsu S, Ichikawa D, Takeshita H, Morimura R, Hirajima S, Tsujiura M, Kawaguchi T, Miyamae M, Nagata H, Konishi H. Circulating miR-18a: a sensitive cancer screening biomarker in human cancer. In Vivo. 2014;28:293–7.
3. Shen K, Cao Z, Zhu R, You L, Zhang T. The dual functional role of MicroRNA-18a (miR-18a) in cancer development. Clin Transl Med. 2019;8:32–44.
4. Dai J, Li X, Xia J, Jin H. Expression and clinical significance of miR-18a and miR-18b in colon cancer. Jiangsu Med. 2011;37:2284–6.
5. Zhou C, Chen Z, Zhao L, Zhao W, Zhu Y, Liu J, Zhao X. A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non–small-cell lung cancer. J Clin Lab Anal. 2020;34(11): e23505.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献